Director of $CR purchases 1,500 shares in insider buy

A recent insider purchase at $CR caught the attention of investors, with Jennifer Pollino, a director at the company, acquiring 1,500 shares on January 29, 2026, for an estimated $276,435. This information was derived from a recent SEC filing and reported by Quiver Quantitative. Pollino’s purchase resulted in an increase in her holdings of this particular class of stock. Following this transaction, Pollino now possesses 1,500 shares of $CR stock.

Over the past six months, $CR insiders have engaged in 12 trades involving the company’s stock. Out of these transactions, 5 were purchases, and 7 were sales. Multiple key figures within the company, such as RICHARD A MAUE (Exec. V.P & CFO), ALEJANDRO ALCALA (Exec. V.P. & Chief Op. Officer), and others, have been actively buying and selling $CR shares, reflecting ongoing insider trading activity within the company.

In terms of hedge fund activity, a significant number of institutional investors have been adjusting their positions regarding $CR stock. While 260 institutions have added shares to their portfolios, 218 have decreased their positions in the most recent quarter. Notable entities such as CAPITAL INTERNATIONAL INVESTORS, BLACKROCK, INC., and PRUDENTIAL FINANCIAL INC. have made substantial changes to their holdings of $CR stock, indicating varying levels of confidence in the company’s future performance.

Despite these fluctuations, $CR reported revenues of $581M in the fourth quarter of 2025, showcasing the company’s financial health and stability during that period. Wall Street analysts are closely monitoring $CR, with two firms issuing buy ratings on the stock in recent months. Analysts at DA Davidson and B of A Securities have both expressed positive views on $CR, reinforcing investor sentiment regarding the company’s potential for growth and success.

Moreover, analysts have also provided price targets for $CR, with the median target standing at $225.0. Notable analysts like Matt Summerville, Nathan Jones, and Ronald Epstein have set varying price targets for $CR, further contributing to the discussion surrounding the company’s valuation and future prospects. Investors and analysts alike continue to track $CR closely, using platforms like Quiver Quantitative to stay informed about the company’s financial performance and market position.